IMMURON LTD IMRN
SPONSORED ADR · ADR · CUSIP 45254U101
Small biotech company
- SectorHealth care
- IndustryPharmaceutical Preparations
- Websiteimmuron.com.au
- FilingsSEC EDGAR
6
institutional holders
128.3k
shares reported held*
$466.0kreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $3.63.
Insider purchases and sales in Q4 2019
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2019.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| COURAGE CAPITAL MANAGEMENT LLC 1.18% of their portfolio | 107.1k $389.0k | — |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 10.1k $37.0k | — |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 7.8k $28.0k | — |
| MORGAN STANLEY 0.00% of their portfolio | 2.3k $8.0k | — |
| LADENBURG THALMANN FINANCIAL SERVICES INC. 0.00% of their portfolio | 1.0k $4.0k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |